Liposome Encapsulation of Ciprofloxacin Improves Protection against Highly Virulent Francisella tularensis Strain Schu S4

被引:22
|
作者
Hamblin, Karleigh A. [1 ]
Armstrong, Stuart J. [1 ]
Barnes, Kay B. [1 ]
Davies, Carwyn [1 ]
Wong, Jonathan P. [2 ]
Blanchard, James D. [3 ]
Harding, Sarah V. [1 ]
Simpson, Andrew J. H. [1 ]
Atkins, Helen S. [1 ]
机构
[1] Def Sci & Technol Lab, Dept Biomed Sci, Salisbury, Wilts, England
[2] Def Res & Dev Canada, Suffield Res Ctr, Ralston, AB, Canada
[3] Aradigm Corp, Hayward, CA USA
关键词
BIOLOGICAL WEAPON; TULAREMIA; INFECTION; EFFICACY; ANTIBIOTICS; MACROPHAGES; DELIVERY; VACCINE; ANTHRAX; MOUSE;
D O I
10.1128/AAC.02555-13
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Liposome-encapsulated ciprofloxacin for inhalation (CFI) was investigated as a putative postexposure therapeutic for two strains of Francisella tularensis. The efficacies of oral ciprofloxacin and intranasally instilled CFI could not be distinguished in a mouse model of infection with the F. tularensis live vaccine strain (LVS), where a single dose of either formulation offered full protection against a lethal challenge. However, mouse studies with the more virulent Schu S4 strain of F. tularensis demonstrated that a higher level of protection against a lethal aerosol infection is provided by CFI than by oral ciprofloxacin. In addition, using this infection model, it was possible to discriminate the efficacy of intranasally instilled CFI from that of aerosolized CFI, with aerosolized CFI providing full protection after just a single dose. The improved efficacy of CFI compared to oral ciprofloxacin is likely due to the high sustained concentrations of ciprofloxacin in the lung. In summary, CFI may be a promising therapy, perhaps enabling the prophylactic regimen to be shortened, for use in the event of a deliberate release of F. tularensis. The prophylactic efficacy of CFI against other biological warfare (BW) threat agents also warrants investigation.
引用
收藏
页码:3053 / 3059
页数:7
相关论文
共 50 条
  • [1] Contribution of Citrulline Ureidase to Francisella tularensis Strain Schu S4 Pathogenesis
    Mahawar, Manish
    Kirimanjeswara, Girish S.
    Metzger, Dennis W.
    Bakshi, Chandra Shekhar
    [J]. JOURNAL OF BACTERIOLOGY, 2009, 191 (15) : 4798 - 4806
  • [2] Direct and Indirect Impairment of Human Dendritic Cell Function by Virulent Francisella tularensis Schu S4
    Chase, Jennifer C.
    Celli, Jean
    Bosio, Catharine M.
    [J]. INFECTION AND IMMUNITY, 2009, 77 (01) : 180 - 195
  • [3] A Francisella tularensis Schu S4 Purine Auxotroph Is Highly Attenuated in Mice but Offers Limited Protection against Homologous Intranasal Challenge
    Pechous, Roger D.
    McCarthy, Travis R.
    Mohapatra, Nrusingh P.
    Soni, Shilpa
    Penoske, Renee M.
    Salzman, Nita H.
    Frank, Dara W.
    Gunn, John S.
    Zahrt, Thomas C.
    [J]. PLOS ONE, 2008, 3 (06):
  • [4] Novel Catanionic Surfactant Vesicle Vaccines Protect against Francisella tularensis LVS and Confer Significant Partial Protection against F-tularensis Schu S4 Strain
    Richard, Katharina
    Mann, Barbara J.
    Stocker, Lenea
    Barry, Eileen M.
    Qin, Aiping
    Cole, Leah E.
    Hurley, Matthew T.
    Ernst, Robert K.
    Michalek, Suzanne M.
    Stein, Daniel C.
    DeShong, Philip
    Vogel, Stefanie N.
    [J]. CLINICAL AND VACCINE IMMUNOLOGY, 2014, 21 (02) : 212 - 226
  • [5] Identification of an Attenuated Substrain of Francisella tularensis SCHU S4 by Phenotypic and Genotypic Analyses
    Lovchik, Julie A.
    Reed, Douglas S.
    Hutt, Julie A.
    Xia, Fangfang
    Stevens, Rick L.
    Modise, Thero
    Barry, Eileen M.
    Wu, Terry H.
    [J]. PATHOGENS, 2021, 10 (06):
  • [6] Genome Sequencing Shows that European Isolates of Francisella tularensis Subspecies tularensis Are Almost Identical to US Laboratory Strain Schu S4
    Chaudhuri, Roy R.
    Ren, Chuan-Peng
    Desmond, Leah
    Vincent, Gemma A.
    Silman, Nigel J.
    Brehm, John K.
    Elmore, Michael J.
    Hudson, Michael J.
    Forsman, Mats
    Isherwood, Karen E.
    Gurycova, Darina
    Minton, Nigel P.
    Titball, Richard W.
    Pallen, Mark J.
    Vipond, Richard
    [J]. PLOS ONE, 2007, 2 (04):
  • [7] In silico functional and structural characterization revealed virulent proteins of Francisella tularensis strain SCHU4
    Goel, Prerna
    Panchal, Tanya
    Kaushik, Nandini
    Chauhan, Ritika
    Saini, Sandeep
    Ahuja, Vartika
    Thakur, Chander Jyoti
    [J]. MOLECULAR BIOLOGY RESEARCH COMMUNICATIONS, 2022, 11 (02) : 73 - 84
  • [8] Identification of Mechanisms for Attenuation of the FSC043 Mutant of Francisella tularensis SCHU S4
    Lindgren, Marie
    Tancred, Linda
    Golovliov, Igor
    Conlan, Wayne
    Twine, Susan M.
    Sjostedt, Anders
    [J]. INFECTION AND IMMUNITY, 2014, 82 (09) : 3622 - 3635
  • [9] Roles of Reactive Oxygen Species-Degrading Enzymes of Francisella tularensis SCHU S4
    Binesse, Johan
    Lindgren, Helena
    Lindgren, Lena
    Conlan, Wayne
    Sjoestedt, Anders
    [J]. INFECTION AND IMMUNITY, 2015, 83 (06) : 2255 - 2263
  • [10] fslE is necessary for siderophore-mediated iron acquisition in Francisella tularensis Schu S4
    Ramakrishnan, Girija
    Meeker, Alexis
    Dragulev, Bojan
    [J]. JOURNAL OF BACTERIOLOGY, 2008, 190 (15) : 5353 - 5361